359 related articles for article (PubMed ID: 6206732)
1. Discovery of a cholecystokinin analogue with partial agonist activity.
Howard JM; Knight M; Jensen RT; Gardner JD
Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD
J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
[TBL] [Abstract][Full Text] [Related]
4. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
Vinayek R; Jensen RT; Gardner JD
Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
[TBL] [Abstract][Full Text] [Related]
5. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
6. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated.
Pearson RK; Hadac EM; Miller LJ
Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263
[TBL] [Abstract][Full Text] [Related]
9. [Role of guanine nucleotide regulatory protein in stimulation of exocrine pancreatic secretion by cholecystokinin in isolated rat pancreatic acini].
Matozaki T
Nihon Naibunpi Gakkai Zasshi; 1988 Oct; 64(10):1051-64. PubMed ID: 2463183
[TBL] [Abstract][Full Text] [Related]
10. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
[TBL] [Abstract][Full Text] [Related]
13. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
[TBL] [Abstract][Full Text] [Related]
14. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
Niederau C; Niederau M; Williams JA; Grendell JH
Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
[TBL] [Abstract][Full Text] [Related]
15. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
Matozaki T; Martinez J; Williams JA
Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
[TBL] [Abstract][Full Text] [Related]
16. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
Tsunoda Y; Owyang C
Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
[TBL] [Abstract][Full Text] [Related]
17. Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin a nor cholecystokinin B receptors mediate amylase secretion in vitro.
Miyasaka K; Shinozaki H; Jimi A; Funakoshi A
Pancreas; 2002 Aug; 25(2):161-5. PubMed ID: 12142739
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
19. Direct modulation of pancreatic CCK receptors and enzyme secretion by insulin in isolated pancreatic acini from diabetic rats.
Otsuki M; Williams JA
Diabetes; 1983 Mar; 32(3):241-6. PubMed ID: 6186556
[TBL] [Abstract][Full Text] [Related]
20. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
